What is SCTX's current stock price?

SCTX (Scribe Therapeutics Inc.) is currently trading at $17.00 with a market cap of $275.1M.

What sector is Scribe Therapeutics Inc. in?

Scribe Therapeutics Inc. (SCTX) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

Back to Market返回行情

SCTX Scribe Therapeutics Inc.

NASDAQHealthcare

$17.00-11.92%OpenMarket Cap: $275.1M

As of 2026-10-22 12:07

Why SCTX matters now

Scribe Therapeutics Inc. (SCTX) is a US stock in Healthcare. The latest InvestLog snapshot shows $17.00 with -11.92% on the session and $275.1M in market capitalization.

The latest indexable market news headline is "Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought" from Fool - Investing News.

Latest News

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just BoughtFool - Investing News · 2026-10-20

Scribe Therapeutics: Underrated In-Vivo Gene Therapy Developer With Near-Term CatalystSeeking Alpha · 2026-10-15

Scribe Therapeutics Inc. (NASDAQ:SCTX) Stock Rated “Moderate Buy” by Wall Street AnalystsDefense World · 2026-09-28

Scribe Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate HighlightsGlobeNewsWire · 2026-09-02

Scribe Therapeutics to Participate in Upcoming Investor ConferencesGlobeNewsWire · 2026-09-01

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

NASDAQ

Beta

0.00

Scribe Therapeutics is a clinical-stage biotechnology company focused on developing in vivo CRISPR-based genetic medicines. The company engineers proprietary technologies to target the genetic drivers of disease, with an initial focus on atherosclerotic cardiovascular disease (ASCVD), aiming to shift treatment from chronic care to preventative intervention.